LPL Financial
CCCC icon

LPL Financial’s C4 Therapeutics CCCC Stock Holding History

LPL Financial’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$649K Buy
246,800
+3,495
+1% +$8.23K ﹤0.01% 4540
2025
Q4 		$465K Buy
243,305
+42,375
+21% +$100K ﹤0.01% 4783
2025
Q3 		$446K Buy
200,930
+4,675
+2% +$11.2K ﹤0.01% 4719
2025
Q2 		$281K Buy
196,255
+2,345
+1% +$3.41K ﹤0.01% 4821
2025
Q1 		$310K Buy
193,910
+123,585
+176% +$369K ﹤0.01% 4549
2024
Q4 		$253K Buy
70,325
+8,150
+13% +$40.5K ﹤0.01% 4663
2024
Q3 		$354K Buy
62,175
+40,075
+181% +$241K ﹤0.01% 4292
2024
Q2 		$102K Buy
+22,100
New +$132K ﹤0.01% 4740

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return